30-Jul-2008 - Shimadzu Corporation

Seegene and Shimadzu Agree to Join Multi-Pathogen Tests and Platform for Combined Analytics Solution

Seegene, Inc. and Shimadzu Corporation announced a strategic partnership to combine Seegene's Seeplex(R) multi-pathogen tests with Shimadzu's MultiNA (1) analytical platform. Under terms of the deal, Shimadzu and Seegene will collaborate on integrating the Seeplex polymerase chain reaction-based tests with Shimadzu's MultiNA high-speed electrophoresis system to provide a highly sensitive, high-throughput multi-pathogen detection and analysis solution.

"This strategic agreement reinforces our plan to bring solutions, and not only products, to our customers," said Dr. Jong-Yoon Chun, Founder and Chief Executive Officer, Seegene. "Shimadzu's MultiNA is outstanding in the market for electrophoresis analysis and a perfect match for the Seeplex family of multi-pathogen tests."

"Seegene's novel multi-pathogen detection test working with Shimadzu's next-generation electrophoresis systems creates an unparalleled screening platform for laboratories around the world," said Yoshiyuki Togawa, General Manager, Shimadzu. "Seeplex tests running on MultiNA is the fast, accurate and efficient way for laboratories to screen for the most rampant and debilitating pathogens infecting people around worldwide."

More about Shimadzu
  • News

    Shimadzu acquires specialist for isotope labeled standards

    Shimadzu has joined forces with the France-based AlsaChim company, an independent contract research and development organization. AlsaChim specializes in stable isotope-labelled compounds, metabolites and pharmaceutical related substances, and analytical purposes. With immediate effect, Shi ... more

  • Videos

    Chip-based automated electrophoresis: parallel processing of up to 108 DNA/RNA samples Untertitel

    The full automated electrophoresis system MultiNA from Shimadzu quickly and easily performs DNA and RNA nucleic acid size confirmation and quantitation. This System uses microchip technology to conduct fully automated high-speed electrophoresis separation and fluorescence detection to perfo ... more

  • White papers

    A granular look at sugar

    Our experience with sugar starts in early childhood – since breast milk contains lactose. Human sensory perception alone is, however, not enough more

    How physics discovered TOC

    The determination of algal biomass using TOC is a new method that has proven to be highly suitable in a laboratory environment for the measurement of biomass more

    New since 5000 years

    Although the ancient Egyptians already used inks 5000 years ago, inks and their properties have been continuously improved and refined over thousands of years. more

  • Companies

    Shimadzu Österreich

    Highest product and service quality, comfortable equipment, system performance and total cost of ownership (TCO) are important parameters to achieve the best results with optimum economy. With this claim, Shimadzu is continuously expanding the technical boundaries and redefining them. Numer ... more

    Shimadzu Deutschland GmbH

    Shimadzu is a world-leading manufacturer of analytical instrumentation. Shimadzu develops and manufactures innovative products for laboratories in industry, science and governmental institutions. With our customer-oriented strategy and our high-quality service, we strive to be Europe's mark ... more

    Shimadzu Schweiz GmbH

    With our Corporate Philosophy "Contributing to Society through Science and Technology", Shimadzu promises customers worldwide to realize our wishes for the well-being of mankind and the Earth. Our new brand statement, "Excellence in Science", reflects our desire and attitude to respond to ... more

More about Seegene
  • News

    Seegene and Molzym partner on automated molecular sepsis diagnostics

    Seegene and Molzym announced a partnership on the automated Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens. "The Magicplex Sepsis Test will be the new gold standard for performing accurate, rapi ... more

    Seegene Awarded Patent for Haplotyping Using Multiplex PCR

    Seegene, Inc announced that it has been awarded international patent protection for a break-through technology able to accelerate the detection of highly personal variations in genetic sequences. These genetic variations can identify an individual's risks for a broad range of disorders, suc ... more

    Seegene Receives Approval from Health Canada for Its Respiratory Virus Multi-Pathogen Detection Tests

    Seegene, Inc. announced that it has received a Medical Device License from Health Canada for its Seeplex(R) RV5 ACE (Auto Capillary Electrophoresis) Screening and RV12 ACE Detection tests. Built on the proprietary Seeplex(R) molecular diagnostic platform, the Canadian healthcare system can ... more

  • Companies

    Seegene, Inc.

    Seegene, Inc. is pioneering the field of multi-pathogen testing. Seegene applies its novel and proprietary Seeplex® system utilizing "DPO (Dual Priming Oligo)" and “ACP (Annealing Control Primer)” to create multi-pathogen tests delivering maximum specificity, reproducibility and sensitivity ... more